Stocks to watch:

Sign in to NFL Now to watch the best of the NFL, personalized for you

Onyx Rejects Amgen's Takeover Bid

TheStreet.com Videos 1:24 mins

Onyx Pharmaceuticals says no to a takeover bid from biotech company Amgen. TheStreet's Brittany Umar has details in Monday's Ahead of the Ticker.

View Comments (0)